The next frontier in immuno-oncology

Actym Therapeutics’ breakthrough platform addresses intractable immune pathways in the tumor microenvironment.

Thumb at
Mar 13, 2019
0
0
Page of
Medium at

Actym Therapeutics

Actym Therapeutics is developing key biotech to help target intractable immune pathways in the tumor microenvironment.

No comments yet.